Skip to content

Clinical trials

Phase 4 Hyperphosphatemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Phase: Phase 4 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20121
20141
20151
20171
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ardelyx2
Winthrop University Hospital2
Fresenius Medical Care North America1
Kaiser Permanente1
Nabi Biopharmaceuticals1
USRC Kidney Research1
University of Colorado, Denver1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia10
Kidney Failure, Chronic3
Renal Insufficiency3
Hyperparathyroidism, Secondary2
Anemia, Iron-Deficiency1
Arteriosclerosis1
Calcinosis1
Cardiovascular Diseases1
Hypercalcemia1
Hypoalbuminemia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.